Hayek Medical Devices

The Cardiac Implications of Positive Pressure Ventilation (PPV) Positive Pressure Ventilation (PPV), commonly used in mechanical ventilation, has both lifesaving benefits and notable adverse effects, particularly concerning cardiovascular function. Several studies have examined these implications, focusing on how PPV can influence heart function and hemodynamics. Cardiac Output and Venous Return PPV increases intrathoracic pressure, compressing major veins like the vena cava and reducing venous return to the heart. This decrease in preload (the blood volume returning to the heart) can significantly reduce cardiac output. A study published in Chest highlighted that this reduction in venous return can cause hypotension in patients with compromised cardiovascular function. Right and Left Ventricular Interaction Increased intrathoracic pressure during PPV can impair right ventricular (RV) function by raising afterload (the resistance the heart pumps against). This forces the right ventricle to work harder, potentially leading to right heart failure in vulnerable patients, as detailed in a Critical Care Medicine review. Coronary Perfusion PPV also impacts coronary blood flow by decreasing diastolic pressure, the phase when coronary perfusion occurs. A study in the American Journal of Respiratory and Critical Care Medicine found that this reduction in coronary perfusion can compromise myocardial oxygenation, especially in patients with pre-existing heart disease, raising the risk of ischemia and arrhythmias. Conclusion While PPV is essential for managing respiratory failure, it can negatively impact cardiovascular function, particularly in individuals with compromised heart health. Clinicians must carefully assess the risks and benefits of PPV—or consider alternative solutions—to ensure the best outcomes for their patients.

We are so happy to be here at AARC 2024 sharing how BCV can help your patient populations. Come see us at booth 941. #AARC2024 #BCV

Positive pressure ventilation can place unnecessary strain on the heart and lungs, complicating recovery for patients. Why stick with methods that decrease CVP? BCV offers non-invasive respiratory support that aligns with natural breathing, providing care that works with your body, not against it. #RespiratoryCare #RespiratoryTherapist #BCV

Managing COPD can be challenging, but modern solutions like Biphasic Cuirass Ventilation (BCV) offer new ways to improve respiratory care. Learn more about how BCV provides non-invasive support and better outcomes for COPD patients: https://buff.ly/3AP7y43 #COPDAwareness #RespiratoryCare #BCV #HealthcareInnovation

Discover how our non-invasive respiratory solution can transform patient care. Curious to see it in action? Schedule a demo and experience the benefits firsthand. Don’t just take our word for it—see how it can make a difference for your patients. Try it today! https://lnkd.in/gnyk4_x7 #HealthcareInnovation #RespiratoryCare #MedicalDevices

Hayek Medical is live at PCICS! ?? Stop by Booth 414 to learn more about Hayek BCV and how we're shaping the future of respiratory care. Don’t miss the chance to meet Erickson Vo and Gary Mefford RRT from our team—they’re here to answer your questions and share insights!? #PCICS2024 #HayekMedical #RespiratoryCare

Does BCV require a prescription? Yes, BCV requires a prescription from your physician. Have questions? Ask us! Our professionals are ready to help. #BCV #RespiratoryCare #HealthcareSupport

Hayek Medical is excited to attending AARC 2024 in Orlando from November 20-23 at the Orange County Convention Center! Join us at Booth 941 to experience Biphasic Cuirass Ventilation (BCV) firsthand. This mask-free, non-invasive solution offers a better support for respiratory care, lung recruitment, and airway clearance. We're looking forward to connecting with respiratory care professionals who are passionate about advancing patient outcomes. #AARC2024 #BCV #RespiratoryCare #HealthcareInnovation

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition characterized by airflow limitation, primarily due to chronic bronchitis and emphysema. Beyond respiratory issues, COPD has significant cardiovascular implications, driven by chronic hypoxia, systemic inflammation, and increased pulmonary vascular resistance. These factors contribute to several cardiac conditions, including: 1?? Pulmonary Hypertension & Right Heart Failure (Cor Pulmonale): In COPD, chronic hypoxia leads to vasconstriction of the pulmonary arteries, which increases pressure in the pulmonary circulation, a condition known as pulmonary hypertension. Over time, the right ventricle of the heart, which pumps blood into the lungs, has to work harder to overcome this increased resistance, leading to the right ventricular hypertrophy and eventually right-sided heart failure, also called cor pulmonale. 2?? Arrhythmias: Hypoxemia and hypercapnia (high CO2 levels) in COPD contributes to electrical instability in the heart, increasing the risk of arrhythmias, particularly atrial fibrillation. The combination of lung disease and heart failure further predisposes patients to irregular heart rhythms. 3?? Coronary Artery Disease (CAD): COPD is associated with systemic inflammation and oxidative stress, both of which accelerate atherosclerosis, increasing the risk of coronary artery disease. COPD patients often have co-existing CAD, which can worsen symptoms like chest pain and dyspnea. Supporting Research: Chest: Up to 30% of COPD patients develop pulmonary hypertension, with many progressing to cor pulmonale. European Respiratory Journal: COPD patients are at a higher risk of atrial fibrillation, which worsens prognosis and increases mortality. The Lancet: COPD patients are twice as likely to develop CAD, partly due to shared risk factors like smoking and systemic inflammation. Effective management of COPD must address cardiovascular complications to improve patient outcomes. Monitoring and treatment of these issues are essential for better overall care. #COPDAwareness #CardiovascularHealth #PulmonaryHypertension #HeartFailure #LungHealth

Hayek Medical is excited to be at the PCICS 2024 in San Diego from November 14-17 at the Town & Country Resort! Discover how Biphasic Cuirass Ventilation (BCV) is advancing pediatric respiratory and cardiac care with mask-free, non-invasive support. Visit us at Booth 414 to experience BCV firsthand and learn how it provides lung recruitment, airway clearance, and comprehensive cardiopulmonary support. We look forward to connecting with clinicians and healthcare professionals dedicated to improving pediatric care! #PCICS2024 #BCV #PediatricCare #RespiratoryHealth